Women not routinely screened for pregnancy prior to chemoimmunotherapy, Aussie study reveals
Associate Professor Nada Hamad says assessing pregnancy status before treatment should be standard care.
![](https://www.ausdoc.com.au/wp-content/uploads/2024/06/Nada-Hamad-300x225.jpg)
Clinicians are calling for mandatory pregnancy tests for women undergoing chemotherapy in combination with immunotherapy.
It follows research from late last year which found only 17% of chemoimmunotherapy cycles screened patients for pregnancy before their treatment began.